edoc-vmtest

FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease

Evstatiev, Rayko and Marteau, Philippe and Iqbal, Tariq and Khalif, Igor L. and Stein, Jürgen and Bokemeyer, Bernd and Chopey, Ivan V. and Gutzwiller, Florian S. and Riopel, Lise and Gasche, Christoph and Fergi Study Group, . (2011) FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease. Gastroenterology, Vol. 141, H. 3 , S. 846-853.e1-2.

Full text not available from this repository.

Official URL: http://edoc.unibas.ch/dok/A6004075

Downloads: Statistics Overview

Abstract

Iron deficiency anemia (IDA) is common in chronic diseases and intravenous iron is an effective and recommended treatment. However, dose calculations and inconvenient administration may affect compliance and efficacy. We compared the efficacy and safety of a novel fixed-dose ferric carboxymaltose regimen (FCM) with individually calculated iron sucrose (IS) doses in patients with inflammatory bowel disease (IBD) and IDA.
Faculties and Departments:03 Faculty of Medicine > Departement Public Health > Pharmazeutische Medizin ECPM > Pharmazeutische Medizin (Szucs)
UniBasel Contributors:Gutzwiller, Florian S.
Item Type:Article, refereed
Article Subtype:Research Article
Publisher:Saunders
ISSN:0016-5085
Note:Publication type according to Uni Basel Research Database: Journal article
Identification Number:
Last Modified:25 Oct 2013 08:33
Deposited On:25 Oct 2013 08:33

Repository Staff Only: item control page